India to Poland: Ledipasvir Export Trade Route
India has recorded 18 verified shipments of Ledipasvir exported to Poland, representing a combined trade value of $14.9K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $830 USD. The leading Indian exporter is LEOWIN HEALTHCARE LLP, which accounts for 68% of total export value with 9 shipments worth $10.2K USD. On the buying side, TO THE ORDER.. is the largest importer in Poland with $5.0K USD in purchases. The top 3 suppliers — LEOWIN HEALTHCARE LLP, HEET HEALTHCARE PRIVATE LIMITED, SACRED LEAVES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Ledipasvir corridor is one of India's established pharmaceutical export routes, with 18 shipments documented worth a combined $14.9K USD. The route is dominated by LEOWIN HEALTHCARE LLP, which alone accounts for roughly 68% of all export value, reflecting the consolidated nature of India's ledipasvir manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $830 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with ledipasvir's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 31.9%, placing it at rank #16 among India's top ledipasvir export destinations globally.
On the import side, key buyers of Indian ledipasvir in Poland include TO THE ORDER.., TO THE ORDER, UNIVERSUM BCL SP. Z O.O. and 6 others. TO THE ORDER.. is the single largest importer with 2 shipments valued at $5.0K USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ4
- Primary modeSea freight
- Top portAHEMDABAD AIR
Market Position
- Global rank#16
- Annual growth+31.9%
- Demand growth+26.6%
- Regulatory ease82/100
Top 10 Indian Ledipasvir Exporters to Poland
Showing top 10 of 3 Indian suppliers exporting Ledipasvir to Poland, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LEOWIN HEALTHCARE LLP Avg $1.1K per shipment | 9 | $10.2K | 68.0% |
| 2 | HEET HEALTHCARE PRIVATE LIMITED Avg $536 per shipment | 8 | $4.3K | 28.7% |
| 3 | SACRED LEAVES PRIVATE LIMITED Avg $500 per shipment | 1 | $500 | 3.3% |
This table shows the top 10 of 3 Indian companies exporting ledipasvir to Poland, ranked by total trade value. The listed exporters are: LEOWIN HEALTHCARE LLP, HEET HEALTHCARE PRIVATE LIMITED, SACRED LEAVES PRIVATE LIMITED. LEOWIN HEALTHCARE LLP is the dominant supplier with 9 shipments worth $10.2K USD, giving it a 68% market share.
Top 10 Ledipasvir Importers in Poland
Showing top 10 of 9 known buyers in Poland receiving Ledipasvir shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ledipasvir in Poland include TO THE ORDER.., TO THE ORDER, UNIVERSUM BCL SP. Z O.O., MAGAZYN CELNY FIRMY, TO THE ORDER OF,,,,,, among 9 total buyers. The largest importer is TO THE ORDER.., accounting for $5.0K USD across 2 shipments — representing 34% of all ledipasvir imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER.. | 2 | $5.0K | 33.7% |
| 2 | TO THE ORDER | 4 | $3.9K | 25.8% |
| 3 | UNIVERSUM BCL SP. Z O.O. | 5 | $3.2K | 21.4% |
| 4 | MAGAZYN CELNY FIRMY | 1 | $882 | 5.9% |
| 5 | TO THE ORDER OF,,,,, | 1 | $700 | 4.7% |
| 6 | UNIVERSUM SP Z O O | 2 | $554 | 3.7% |
| 7 | DM GROUP PLANET SP Z O O SP K | 1 | $500 | 3.3% |
| 8 | UNIVERSUM BCL SP Z O O | 1 | $120 | 0.8% |
| 9 | UNIVERSUM BCL SP ZOO UL LWOWSKA | 1 | $83 | 0.6% |
Top 10 Ledipasvir Formulations Imported by Poland
Showing top 10 of 16 product formulations shipped on the India to Poland Ledipasvir route, ranked by trade value
Poland imports a wide range of ledipasvir formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PRODUCT NAME:LEDIPASVIR 90MG & SOFOSBUVIR 400MG TABLETSNOS — accounts for $5.0K USD across 2 shipments. There are 16 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PRODUCT NAME:LEDIPASVIR 90MG & SOFOSBUVIR 400MG TABLETSNOS | 2 | $5.0K | 33.7% |
| 2 | (PHARMA ITEM) LEDIPASVIR 90MG & SOFOSBUVIR 400MG TABLET - LEDIPASVIR 90MG & SOFOSBUVIR 400MG TABLET(AS PER INV) | 1 | $1.9K | 12.9% |
| 3 | LEDIPASVIR 90MG & SOFOSBUVIR 400MG OTHERDETAILS AS PER INVOICENOS | 1 | $1.8K | 11.8% |
| 4 | LEDIPASVIR 90 MG & SOFOSBUVIR 400 MG TABLETS- LET(OTHER DETAILS AS PER INV) | 1 | $900 | 6.0% |
| 5 | (PHARMA ITEM)Ledifos Tablet -Ledipasvir90mg & Sofosbuvir 400mg Tablet (OTHER DETAILS AS PER INV) | 1 | $882 | 5.9% |
| 6 | (PHARMA ITEMS)LEDIPASVIR 90MG & SOFOSBUVIR 400MG TABLETS -LEDIPASVIR 90MG & SOFOSBUVIR 400MG TABLETS(AS PER INV) | 1 | $871 | 5.8% |
| 7 | SOFOSBUVIR 400MG & LEDIPASVIR 90MG TABLETS BATCH NO .HH2309429 MFG DATE.SEP-23 EXP DATE.AUG-26 AS PER INVOICE. | 1 | $700 | 4.7% |
| 8 | (PHARMA ITEM)LEDIPASVIR 90MG & SOFOSBUVIR 400MG TABLET -LEDIPASVIR 90MG&SOFOSBUVIR 400MG TAB (OTHER DETAILS AS PER INV) | 1 | $601 | 4.0% |
| 9 | LEDIFOS TABLETS LEDIPASVIR 90MG & SOFOSB | 2 | $554 | 3.7% |
| 10 | LEDIPASVIR 90MG 28 TAB BOTTLE BATCH HH2211521 MFG 11 22 EXP 10 24 | 1 | $500 | 3.3% |
Showing top 10 of 16 Ledipasvir formulations imported by Poland on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
AHEMDABAD AIR handles the highest volume with 11 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's ledipasvir exports to Poland are driven primarily by a handful of large-scale manufacturers. LEOWIN HEALTHCARE LLP with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LEOWIN HEALTHCARE LLP, HEET HEALTHCARE PRIVATE LIMITED, SACRED LEAVES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $830 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as (pharma item) ledipasvir 90mg & sofosbuvir 400mg tablet - ledipasvir 90mg & sofosbuvir 400mg tablet(as per inv) and ledipasvir 90mg & sofosbuvir 400mg otherdetails as per invoicenos, suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER.. is the largest importer with 2 shipments worth $5.0K USD — representing 34% of all ledipasvir imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $14.9K
- Avg. Shipment
- $830
- Suppliers
- 3
- Buyers
- 9
- Transit (Sea)
- ~26 days
- Annual Growth
- +31.9%
Related Analysis
Other Ledipasvir Routes
Unlock the Full India to Poland Ledipasvir Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 18 shipments on this route.
Frequently Asked Questions — India to Poland Ledipasvir Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ledipasvir to Poland?
The leading Indian exporters of Ledipasvir to Poland are LEOWIN HEALTHCARE LLP, HEET HEALTHCARE PRIVATE LIMITED, SACRED LEAVES PRIVATE LIMITED. LEOWIN HEALTHCARE LLP holds the largest market share at approximately 68% of total trade value on this route.
Q What is the total value of Ledipasvir exports from India to Poland?
India exports Ledipasvir to Poland worth approximately $14.9K USD across 18 recorded shipments. The average value per shipment is $830 USD.
Q Which ports does India use to ship Ledipasvir to Poland?
The most active port of origin is AHEMDABAD AIR with 11 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Poland for Ledipasvir?
The average transit time for Ledipasvir shipments from India to Poland is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Poland Ledipasvir trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.9% with demand growth tracking at 26.6%. The route is ranked #16 among India's top Ledipasvir export destinations globally.
Q How many suppliers are active on the India to Poland Ledipasvir route?
There are currently 3 active Indian suppliers exporting Ledipasvir to Poland. The market is moderately concentrated with LEOWIN HEALTHCARE LLP accounting for 68% of total shipment value.
Q Who are the main importers of Ledipasvir from India in Poland?
The leading importers of Indian Ledipasvir in Poland include TO THE ORDER.., TO THE ORDER, UNIVERSUM BCL SP. Z O.O., MAGAZYN CELNY FIRMY, TO THE ORDER OF,,,,,. TO THE ORDER.. is the largest buyer with 2 shipments worth $5.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Poland export trade corridor identified from Indian Customs (DGFT) records for Ledipasvir.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 9 importers in Poland matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 18 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
18 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists